NLRP3 and cryopyrin-associated periodic syndrome: Although NLRP3 expression in CAPS patients with active diseases is comparable to that of healthy donors, as per GEO datasets (GSE57253)30, LPS has been commonly used in previous studies to stimulate IL-1β expression and release from CAPS samples10–16.